Federated Hermes, Inc. 13D and 13G filings for Albireo Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-10 11:22 am Sale |
2023-03-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
0 0.000% |
-1,956,488 (Position Closed) |
Filing |
| 2023-02-01 09:07 am Sale |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
1,956,488 9.450% |
-402,136 (-17.05%) |
Filing |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
2,358,624 12.230% |
-88,376 (-3.61%) |
Filing |
| 2022-02-14 1:31 pm Purchase |
2021-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
5,280,847 6.500% |
998,284 (+23.31%) |
Filing |
| 2021-02-12 1:16 pm Purchase |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
4,282,563 5.400% |
516,198 (+13.71%) |
Filing |
| 2021-02-12 1:16 pm Purchase |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
2,447,000 12.830% |
1,010,000 (+70.29%) |
Filing |
| 2020-11-10 1:32 pm Sale |
2020-10-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
3,766,365 4.750% |
-49,935 (-1.31%) |
Filing |